Congress asks FDA chief to testify on J&J recall; Ranbaxy recalls three European product batches;

 @FiercePharma:  Pfizer manufacturing overhaul claims 8 plants, 6,000 jobs. Article | Follow @FiercePharma

> FDA Commissioner Margaret Hamburg has been asked to testify at the May 27 Congressional hearing that will probe Johnson & Johnson's recent recall of more than 40 children's and infants' medications, as new details emerge about the problems with those drugs. Report | Report

> India's Ranbaxy Laboratories said its European unit was recalling select batches of three products to add safety warnings under the regulations there. Report

> A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported. Report

> Pfizer's Revatio, which is identical to Viagra but in different dosage, missed the main goal of a study in an advanced form of a fatal lung disease, although improvements in some symptoms may aid patients that currently have no options. Report

> Sinclair Pharma said the new management's restructuring strategy is driving a significant business turnaround with a strong recovery in its Italian market and a new strategy in France leading a recovery. Report

> Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity. Report

Biotech News

 @FierceBiotech: Biopharma execs predict a big spike in M&A deals. Report | Follow @FierceBiotech

 @JohnCFierce: Pfizer gets Wash U researchers to take a second look at its molecules. Article | Follow @JohnCFierce

> Roche, Biogen shutter blockbuster ocrelizumab arthritis program. Story

> Biotech investors brace for annual ASCO data dump. Report

> NicOx delays a PhII as it deals with NSAID setback. Article

> BIO boosts lobbying efforts in Q1. Report

Drug Delivery News

> Pearl reports inhaled COPD drug results. Item

> Topical HIV/AIDS vax gets nanomedicine formulation. Story

> Obesity pill data demonstrates efficacy. News

> Otonomy presents preclinical hearing loss data. Report

Medical Device News

> GE Healthcare invests $5M in CardioDx. News

> Virtual Radiologic purchased for $294M. Story

> Breathe Technologies secures $23M in financing. Report

> Merit inks merger deal with BioSphere. Item

> CDRH joins Twitter. Story

> Nautic completes Medegen sale to CareFusion. Article

And Finally... Patients whose doctors over-prescribe antibiotics may develop drug resistance that lasts up to a year, putting them and the population at risk when more serious treatment is needed, scientists said. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.